Midregional Pro-A-Type Natriuretic Peptide for Diagnosis and Prognosis in Patients With Suspected Acute Myocardial Infarction

被引:12
|
作者
Meune, Christophe [1 ,3 ]
Twerenbold, Raphael [1 ,2 ]
Drexler, Beatrice [1 ,2 ]
Balmelli, Cathrin [1 ]
Wolf, Claudia [1 ,2 ]
Haaf, Philip [1 ,2 ]
Reichlin, Tobias [1 ,2 ]
Irfan, Affan [1 ]
Reiter, Miriam [1 ,2 ]
Zellweger, Christa [1 ,2 ]
Meissner, Julia [1 ]
Stelzig, Claudia [1 ]
Freese, Michael [1 ]
Capodarve, Isabel [4 ,5 ]
Mueller, Christian [1 ,2 ]
机构
[1] Univ Basel Hosp, Dept Internal Med, CH-4031 Basel, Switzerland
[2] Univ Basel Hosp, Dept Cardiol, CH-4031 Basel, Switzerland
[3] Paris Descartes Univ, Cochin Hosp, APHP, Dept Cardiol, Paris, France
[4] UPF, CIBERES, ISC 3, Hosp del Mar IMIM,Serv Pneumol, Barcelona, Spain
[5] Hosp del Mar IMIM, Serv Urgencias, Barcelona, Spain
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2012年 / 109卷 / 08期
基金
瑞士国家科学基金会;
关键词
ACUTE CORONARY SYNDROME; TIMI RISK SCORE; CHEST-PAIN POPULATION; ST-SEGMENT ELEVATION; LONG-TERM SURVIVAL; EMERGENCY-DEPARTMENT; STRATIFICATION; ISCHEMIA; PLASMA; BIOMARKERS;
D O I
10.1016/j.amjcard.2011.11.047
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We hypothesized that midregional pro-A-type natriuretic peptide (MR-proANP), the stable midregional epitope of proANP, might be useful in the early diagnosis and risk stratification of patients with suspected acute myocardial infarction (AMI). In this multi-center study we measured MR-proANP, cardiac troponin T (cTnT), and high-sensitive cTnT (hs-cTnT) at presentation in 675 consecutive patients presenting to the emergency department with suspected AMI. The final diagnosis was adjudicated by 2 independent cardiologists. Patients were followed 360 days for mortality and AMI. AMI was the final diagnosis in 119 patients (18%). Median MR-proANP levels at presentation were significantly higher in patients with AMI (189 pmol/L, interquartile range 97 to 341) versus patients with another final diagnosis (83 pmol/L, 49 to 144, p < 0.001). However, neither the combination of MR-proANP with cTnT nor its combination with hs-cTnT significantly improved diagnostic accuracy as quantified by area under the receiver operating characteristic curve (0.91 vs 0.89 for cTnT alone, p = 0.086; 0.95 vs 0.96 for hs-cTnT, respectively, p = 0.02). Cumulative 360-day mortality/AMI rates were 2.4% in the first, 3.6% in the second, 9.5% in the third, and 18.8% in the fourth quartiles of MR-proANP (p < 0.001). MR-proANP (area under the curve 0.76) predicted mortality/AMI independently of and more accurately than cTnT (area under the curve 0.62), hs-cTnT (area under the curve 0.71), and Thrombolysis In Myocardial Infarction risk score (area under the curve 0.72). Net reclassification improvements offered by the additional use of MR-proANP were 0.388 (p < 0.001), 0.425 (p < 0.001), and 0.217 (p = 0.007), respectively. In conclusion, MR-proANP improves risk prediction for 360-day mortality/AMI but does not seem to help in the early diagnosis of AMI. (C) 2012 Elsevier Inc. All rights reserved. (Am J Cardiol 2012; 109:1117-1123)
引用
收藏
页码:1117 / 1123
页数:7
相关论文
共 50 条
  • [31] THE PROGNOSIS OF PATIENTS SUSPECTED OF HAVING ACUTE MYOCARDIAL-INFARCTION SUBSEQUENT TO ITS EXCLUSION AS THE DIAGNOSIS
    KARLSON, BW
    HERLITZ, J
    EMANUELSSON, H
    KARLSSON, T
    HJALMARSON, A
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1990, 26 (03) : 251 - 257
  • [32] B-type natriuretic peptide infusions in acute myocardial infarction
    Hillock, R. J.
    Frampton, C. M.
    Yandle, T. G.
    Troughton, R. W.
    Lainchbury, J. G.
    Richards, A. M.
    HEART, 2008, 94 (05) : 617 - 622
  • [33] EFFECT OF DIFFERENT REPERFUSION STRATEGY ON BRAIN NATRIURETIC PEPTIDE LEVELS AND PROGNOSIS OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
    Hu Xianqing
    Fu Shenwen
    Hu Xianqing
    HEART, 2012, 98 : E89 - E89
  • [34] Natriuretic peptide insights in acute myocardial infarction
    Ezekowitz, JA
    Theroux, P
    Chang, WC
    Mahaffey, KW
    Granger, CB
    Weaver, WD
    Armstrong, PW
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 228A - 228A
  • [35] Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction
    Darbar, D
    Davidson, NC
    Gillespie, N
    Choy, AMJ
    Lang, CC
    Shyr, Y
    McNeill, GP
    Pringle, TH
    Struthers, AD
    AMERICAN JOURNAL OF CARDIOLOGY, 1996, 78 (03): : 284 - 287
  • [36] Gender difference in B-type natriuretic peptide levels in patients with acute myocardial infarction
    Yoshida, Akemi
    Kawakami, Rika
    Nakanishi, Mitio
    Ibuki, Motoaki
    Noguchi, Teruo
    Otsuka, Yoritaka
    Nonogi, Hiroshi
    Goto, Yoichi
    JOURNAL OF CARDIAC FAILURE, 2008, 14 (07) : S158 - S158
  • [37] N-terminal pro-B-type natriuretic peptide is associated with aortic stiffness in patients presenting with acute myocardial infarction
    Feistritzer, Hans-Josef
    Reinstadler, Sebastian J.
    Klug, Gert
    Kremser, Christian
    Rederlechner, Andrea
    Mair, Johannes
    Mueller, Silvana
    Franz, Wolfgang-Michael
    Metzler, Bernhard
    EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2016, 5 (08) : 560 - 567
  • [38] Early diagnosis of rats with acute myocardial infarction by measurement of brain natriuretic peptide
    Li, Jian
    Yin, Fang-Fang
    Hou, Ying-Long
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 5 (04) : 1201 - 1205
  • [39] Release kinetics of B-type natriuretic peptide signal peptide (BNPsp) in patients with acute myocardial infarction
    Liebetrau, C.
    Doerr, O. D.
    Gaede, L. G.
    Berkowitsch, A. B.
    Troidl, C. T.
    Hamm, C. H.
    Nef, H. N.
    Moellmann, H. M.
    Richards, A. M. R.
    Pemberton, C. P.
    EUROPEAN HEART JOURNAL, 2015, 36 : 71 - 71
  • [40] Rapid determination of brain natriuretic peptide in patients with acute myocardial infarction
    Panteghini, M
    Cuccia, C
    Bonetti, G
    Pagani, F
    Giubbini, R
    Bonini, E
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, 41 (02) : 164 - 168